{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:38:06Z","timestamp":1786977486164,"version":"build-2736575974"},"reference-count":44,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":63,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress Anxiety"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1002\/da.22378","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T16:15:35Z","timestamp":1435680935000},"page":"605-613","source":"Crossref","is-referenced-by-count":36,"title":["THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS\u2019 PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS"],"prefix":"10.1155","volume":"32","author":[{"given":"Joseph F.","family":"Goldberg","sequence":"first","affiliation":[{"name":"Department of Psychiatry; Icahn School of Medicine at Mount Sinai, New York; New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene P.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Massachusetts General Hospital; Boston Massachusetts"},{"name":"Department of Psychiatry; Harvard Medical School; Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Balon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences; Wayne State University; Detroit Michigan"},{"name":"Department of Anesthesiology; Wayne State University; Detroit Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Citrome","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences; New York Medical College; Valhalla New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Thase","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Perelman School of Medicine; University of Pennsylvania; Philadelphia Pennsylvania"},{"name":"Department of Psychiatry; Philadelphia Veterans Affairs Medical Center; Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kane","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Zucker Hillside Hospital-North Shore Long Island Jewish Health System; Glen Oaks New York"},{"name":"Department of Psychiatry; Hofstra North Shore-Long Island Jewish School of Medicine; Uniondale New York"},{"name":"Behavior Health Services; North Shore-Long Island Jewish Health System; New Hyde Park New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fava","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Massachusetts General Hospital; Boston Massachusetts"},{"name":"Department of Psychiatry; Harvard Medical School; Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"issue":"3","key":"10.1002\/da.22378-BIB0001|da22378-cit-0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000091771","article-title":"Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice","volume":"75","author":"Fava","year":"2006","journal-title":"Psychother Psychosom"},{"issue":"12","key":"10.1002\/da.22378-BIB0002|da22378-cit-0002","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1002\/da.22378-BIB0003|da22378-cit-0003","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1002\/da.22378-BIB0004|da22378-cit-0004","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1176\/ajp.2007.164.5.739","article-title":"Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report","volume":"164","author":"Thase","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22378-BIB0005|da22378-cit-0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archpsyc.65.8.870","article-title":"Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment failures","volume":"65","author":"Rush","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"10.1002\/da.22378-BIB0006|da22378-cit-0006","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/appi.ajp.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22378-BIB0007|da22378-cit-0007","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.jcp.0000169036.40755.16","article-title":"Empirical testing of two models for staging antidepressant treatment resistance","volume":"25","author":"Petersen","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1002\/da.22378-BIB0008|da22378-cit-0008","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1600-0447.2009.01434.x","article-title":"Do the old psychostimulant drugs have a role in managing treatment- resistant depression?","volume":"121","author":"Parker","year":"2010","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1002\/da.22378-BIB0009|da22378-cit-0009","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/YIC.0000000000000051","article-title":"Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo controlled trial","volume":"30","author":"McElroy","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"issue":"12","key":"10.1002\/da.22378-BIB0010|da22378-cit-0010","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4088\/JCP.v67n1203","article-title":"Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review","volume":"67","author":"Ruh\u00e9","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1002\/da.22378-BIB0011|da22378-cit-0011","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/070674370004500509","article-title":"Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians","volume":"45","author":"Mischoulon","year":"2000","journal-title":"Can J Psychiatry"},{"issue":"9","key":"10.1002\/da.22378-BIB0012|da22378-cit-0012","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1002\/da.22378-BIB0013|da22378-cit-0013","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in patients with anxious versus nonanxious depression: a STAR*D report","volume":"165","author":"Fava","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1002\/da.22378-BIB0014|da22378-cit-0014","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1017\/S1461145711001660","article-title":"Correlates and outcomes of depressed out- patients with greater and fewer anxious symptoms: a CO-MED report","volume":"15","author":"Chan","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1002\/da.22378-BIB0015|da22378-cit-0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/appi.ajp.2009.09020186","article-title":"Combination of antidepressant medications from treatment initiation for major depressive disorder","volume":"167","author":"Blier","year":"2010","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1002\/da.22378-BIB0016|da22378-cit-0016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4088\/JCP.v59n0306","article-title":"A meta-analysis of eight randomized, double-blind, controlled trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety","volume":"59","author":"Fawcett","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1002\/da.22378-BIB0017|da22378-cit-0017","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.euroneuro.2010.12.007","article-title":"Review of atypical antipsychotics in anxiety","volume":"21","author":"Vulink","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"10.1002\/da.22378-BIB0018|da22378-cit-0018","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.v66n0510","article-title":"Why isn't bupropion the most frequently prescribed antidepressant?","volume":"66","author":"Zimmerman","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.22378-BIB0019|da22378-cit-0019","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4088\/JCP.v69n0812","article-title":"Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies","volume":"69","author":"Papakostas","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1002\/da.22378-BIB0020|da22378-cit-0020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/archpsyc.1985.01790350022005","article-title":"Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression","volume":"42","author":"Stewart","year":"1985","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1002\/da.22378-BIB0021|da22378-cit-0021","first-page":"165","article-title":"A double-blind comparative study of desipramine hydrochloride and diazepam in the control of mixed anxiety\/depression symptomatology","volume":"40","author":"Kleber","year":"1979","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1002\/da.22378-BIB0022|da22378-cit-0022","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archpsyc.1976.01770030057008","article-title":"A multiple-dose, controlled study of phenelzine in depression-anxiety states","volume":"33","author":"Ravaris","year":"1976","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10.1002\/da.22378-BIB0023|da22378-cit-0023","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archpsyc.1982.04290090035008","article-title":"Response to phenelzine and amitriptyline in subtypes of outpatient depression","volume":"39","author":"Paykel","year":"1982","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1002\/da.22378-BIB0024|da22378-cit-0024","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00004714-198808000-00003","article-title":"The influence on panic attacks on response to phenelzine and amitriptyline in depressed outpatients","volume":"8","author":"Kayser","year":"1988","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"10.1002\/da.22378-BIB0025|da22378-cit-0025","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force on antidepressant use in bipolar disorders","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1002\/da.22378-BIB0026|da22378-cit-0026","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1192\/bjp.164.4.549","article-title":"Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants","volume":"164","author":"Peet","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1002\/da.22378-BIB0027|da22378-cit-0027","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","article-title":"Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline","volume":"189","author":"Post","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1002\/da.22378-BIB0028|da22378-cit-0028","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4088\/JCP.08m04909gre","article-title":"Antidepressant discontinuation in bipolar depression: a systematic treatment enhancement program for bipolar disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety","volume":"71","author":"Ghaemi","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1002\/da.22378-BIB0029|da22378-cit-0029","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4088\/JCP.08m04191","article-title":"Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study","volume":"70","author":"Altshuler","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1002\/da.22378-BIB0030|da22378-cit-0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1399-5618.2001.30401.x","article-title":"Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines","volume":"3","author":"Lim","year":"2001","journal-title":"Bipolar Disord"},{"issue":"12","key":"10.1002\/da.22378-BIB0031|da22378-cit-0031","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1017\/S0033291705005933","article-title":"Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project","volume":"35","author":"Dennehy","year":"2005","journal-title":"Psychol Med"},{"issue":"4","key":"10.1002\/da.22378-BIB0032|da22378-cit-0032","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/NMD.0b013e3182125d4c","article-title":"Adherence to guidelines by French psychiatrists in their real world of clinical practice","volume":"199","author":"Samalin","year":"2011","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"10.1002\/da.22378-BIB0033|da22378-cit-0033","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MLR.0b013e3181ca27f6","article-title":"Which physician and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders?","volume":"48","author":"Smolders","year":"2010","journal-title":"Med Care"},{"issue":"2","key":"10.1002\/da.22378-BIB0034|da22378-cit-0034","first-page":"189","article-title":"Adherence to Turkish psychiatric association guideline for bipolar depression treatment in a specialized mood disorders outpatient unit","volume":"23","author":"Altinba\u015f","year":"2011","journal-title":"Psychiatr Danub"},{"issue":"3","key":"10.1002\/da.22378-BIB0035|da22378-cit-0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1185\/030079906X167444","article-title":"Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians","volume":"23","author":"Perlis","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1002\/da.22378-BIB0036|da22378-cit-0036","first-page":"CD004857","article-title":"Oxcarbazepine for acute affective episodes in bipolar disorder","volume":"12","author":"Vasudev","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1002\/da.22378-BIB0037|da22378-cit-0037","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2007-1014572","article-title":"High dose tranylcypromine therapy for refractory depression","volume":"22","author":"Amsterdam","year":"1989","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1002\/da.22378-BIB0038|da22378-cit-0038","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S1092852912000508","article-title":"High-dose desvenlafaxine in outpatients with major depressive disorder","volume":"17","author":"Ferguson","year":"2012","journal-title":"CNS Spectr"},{"issue":"6","key":"10.1002\/da.22378-BIB0039|da22378-cit-0039","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00406-005-0579-5","article-title":"Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review","volume":"255","author":"Adli","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1002\/da.22378-BIB0040|da22378-cit-0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.jcp.0000219922.19305.08","article-title":"Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies","volume":"26","author":"Thase","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"10.1002\/da.22378-BIB0041|da22378-cit-0041","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1521-0391.2014.12143.x","article-title":"Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency","volume":"23","author":"Suzuki","year":"2014","journal-title":"Am J Addict"},{"issue":"3","key":"10.1002\/da.22378-BIB0042|da22378-cit-0042","article-title":"Use of bright light therapy among psychiatrists in Massachusetts: an e-mail survey","volume":"16","author":"Oldham","year":"2014","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1002\/da.22378-BIB0043|da22378-cit-0043","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/0092623X.2013.788111","article-title":"Prescribing of phosphodiesterase-5 inhibitors among psychiatrists","volume":"40","author":"Balon","year":"2014","journal-title":"J Sex Marital Ther"},{"key":"10.1002\/da.22378-BIB0044|da22378-cit-0044","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000324795","article-title":"Declining participation in research studies","volume":"80","author":"Arfken","year":"2011","journal-title":"Psychother Psychosom"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22378","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/da.22378\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T08:03:57Z","timestamp":1671523437000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.22378"}},"subtitle":["Research Article: Mood Disorders Prescribing Survey"],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/da.22378","relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,30]]}}}